Cryptococcus: The Ultimate Mimicker
M. Mody(Newark Beth Israel Medical Center), C. Migliore(Newark Beth Israel Medical Center), A. Arjuna(Tucson Orthopaedic Institute), Christopher Nnaoma(Newark Beth Israel Medical Center), Preeti Patel(Indo Soviet Friendship College of Pharmacy), T. Anandarangam(Newark Beth Israel Medical Center)
Cited by 1
Related Papers
Advancement in Solubilization Approaches: A Step towards Bioavailability Enhancement of Poorly Soluble Drugs
|Life|2023|209
A comprehensive review on doxorubicin: mechanisms, toxicity, clinical trials, combination therapies and nanoformulations in breast cancer
|Drug Delivery and Translational Research|2024|141
Alternatives of Animal Models for Biomedical Research: a Comprehensive Review of Modern Approaches
|Stem Cell Reviews and Reports|2024|85
Pyrazolopyrimidines as anticancer agents: A review on structural and target-based approaches
|European Journal of Medicinal Chemistry|2021|72
Furan and benzofuran derivatives as privileged scaffolds as anticancer agents: SAR and docking studies (2010 to till date)
|Journal of Molecular Structure|2023|60